Quoting Razelle Kurzrock, Chair of Precision Oncology at Moore’s Cancer Centre, on X/Twitter:
“At the Right Dose.
Personalized/precision medicine requires individualized dosing, not just customized drug regimens. And individualized dosing with intra-patient dose escalation are the key to safely dosing de novo combinations AND optimized dosing of known regimens.”
Source: Razelle Kurzrock/Twitter.